| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $359.1B | $309.0B | $276.7B | $264.0B | $59.1B | $58.5B | $52.4B | $51.6B |
| Cost of Revenue | $345.7B | $296.1B | $264.4B | $250.8B | $226.1B | $219.0B | $202.6B | $197.2B |
| Gross Profit | $13.3B | $12.8B | $12.4B | $13.1B | $3.3B | $3.3B | $3.2B | $3.1B |
| R&D Expense | — | — | — | — | — | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $8.5B | $8.7B | $7.8B | $10.5B | $8.8B | $9.2B | $8.4B | $8.1B |
| Operating Income | $4.4B | $3.9B | $4.4B | $2.0B | $-5.0B | $2.5B | $0.9B | $0.8B |
| Net Income | $3.3B | $3.0B | $3.6B | $1.1B | $0.7B | $1.0B | $-0.8B | $-1.1B |
| EPS (Basic) | $25.86 | $22.54 | $25.23 | $7.32 | $4.19 | $5.89 | $-4.17 | $-5.58 |
| EPS (Diluted) | $25.72 | $22.39 | $25.03 | $7.23 | $4.15 | $5.85 | $-4.17 | $-5.58 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $75.1B | $67.4B | $62.3B | $63.3B | $65.0B | $61.2B | $59.7B | $60.4B |
| Current Assets | $55.4B | $48.0B | $44.3B | $46.2B | $45.4B | $42.2B | $38.5B | $37.1B |
| Cash & Equivalents | $5.7B | $4.6B | $4.7B | $3.5B | $6.3B | $4.0B | $3.0B | $2.7B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $61.6B | $52.4B | $48.0B | $48.5B | $44.1B | $42.6B | $37.6B | $36.7B |
| Stockholders' Equity | $-2.1B | $-2.0B | $-1.9B | $-2.3B | $-0.0B | $5.1B | $8.1B | $9.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.1B | $4.3B | $5.2B | $4.4B | $4.5B | $4.4B | $4.0B | $4.3B |
| Investing Cash Flow | $-0.7B | $-1.1B | $-0.5B | $-0.1B | $-0.4B | $-0.6B | $-1.4B | $-1.5B |
| Capital Expenditures | $0.5B | $0.4B | $0.4B | $0.4B | $0.5B | $0.4B | $0.4B | $0.4B |
| Financing Cash Flow | $-4.0B | $-3.3B | $-4.4B | $-6.3B | $-1.7B | $-2.7B | $-2.2B | $-3.1B |